|
|
|
|
|
| |
Clinical Trial Results - Tricor |
|
|
|
|
|
|
|
|
|
| CFEN0203 |
A randomized, double-blind trial comparing the efficacy and safety of fenofibrate, metformin, their combination and placebo in patients with metabolic syndrome |
Results summary
|
M. Nieuwdorp, E.S.G. Stroes and J.J.P Kastelein Normalisation of metabolic syndrome using fenofibrate metformin or their combination. Diabetes. Obesity and Metabolism. 9, 2007, 869-878
|
| CFEN0205 |
A randomised, double-blind, placebo-controlled study assessing the effect of fenofibrate, coenzyme Q10 and their co-administration on ventricular diastolic function in patients with type 2 diabetes |
Results summary
|
Gerard T Chew and al, Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction. Diabetes Care 2008
|
| CLF230121-0301 |
A randomized, double-blind trial assessing the efficacy and safety of low and standard doses of fenofibrate in combination with metformin on the lipid profile in patients with type 2 diabetes and dyslipidemia. |
Results summary
|
none available
|
|
CLF178P-0401
|
A randomised, double-blind study comparing the efficacy and safety of 145 mg NanoCrystal® fenofibrate, 10 mg ezetimibe and their combination in patients with type IIb dyslipidemia and features of the metabolic syndrome. |
Results summary
|
Jean-Claude Ansquer and al, Efficacy and Safety of Coadministration of Fenofibrate and Ezetimibe Compared with Each as Monotherapy in Patients with Type IIb Dyslipidemia and Features of the Metabolic Syndrome. American Journal of Cardiovascular Drugs 2009; 9 (2): 91-101
|
| CLF230121-0503 |
Assessment of insulin sensitivity in type 2 diabetics treated with metformin, fenofibrate and their combination |
Results summary
|
none available
|
| |
|
|
|
|
|
|
|
|
|
|
|
